Jyong Biotech Ltd. Ordinary Shares (MENS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−75.8x

Market Cap

$181.71M

MomentumView details →

1D Return

+5.29%

YTD Return

−39.49%

RSI (14)

62.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−75.8x

Market Cap

$181.71M

RSI (14)

62.6

MomentumView details →

1D Return

+5.29%

YTD Return

−39.49%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

18.76%

ROA (TTM)

−22.49%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−61.21%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−0.74x

Current Ratio

0.45x

Quick Ratio

0.45x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−4.67M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for MENS.

Similar companies

Tharimmune, Inc.CNTN Korro Bio, Inc.KRRO Immunic, Inc.IMUX LENZ Therapeutics, Inc.LENZ ADC Therapeutics S.A.ADCT Kazia Therapeutics LimitedKZIA Find similar companies →

Latest newsMore news →

No recent news for MENS.